Terms: = Lung cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
49 results:
1. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
Kasikova L; Rakova J; Hensler M; Lanickova T; Tomankova J; Pasulka J; Drozenova J; Mojzisova K; Fialova A; Vosahlikova S; Laco J; Ryska A; Dundr P; Kocian R; Brtnicky T; Skapa P; Capkova L; Kovar M; Prochazka J; Praznovec I; Koblizek V; Taskova A; Tanaka H; Lischke R; Mendez FC; Vachtenheim J; Heinzelmann-Schwarz V; Jacob F; McNeish IA; Halaska MJ; Rob L; Cibula D; Orsulic S; Galluzzi L; Spisek R; Fucikova J
Nat Commun; 2024 Mar; 15(1):2528. PubMed ID: 38514660
[TBL] [Abstract] [Full Text] [Related]
2. Targeted inhibition of the hnf1a/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer.
Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG
Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910
[TBL] [Abstract] [Full Text] [Related]
3. High HPK1
Zhang J; Ren Z; Hu Y; Shang S; Wang R; Ma J; Zhang Z; Wu M; Wang F; Yu J; Chen D
Int Immunopharmacol; 2024 Jan; 127():111363. PubMed ID: 38101218
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics and anatomic location of PD-1
Im SJ; Obeng RC; Nasti TH; McManus D; Kamphorst AO; Gunisetty S; Prokhnevska N; Carlisle JW; Yu K; Sica GL; Cardozo LE; Gonçalves ANA; Kissick HT; Nakaya HI; Ramalingam SS; Ahmed R
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221985120. PubMed ID: 37782797
[TBL] [Abstract] [Full Text] [Related]
5. High endothelial venules predict response to PD-1 inhibitors combined with anti-angiogenesis therapy in NSCLC.
Ye D; Jin Y; Weng Y; Cui X; Wang J; Peng M; Song Q
Sci Rep; 2023 Sep; 13(1):16468. PubMed ID: 37777573
[TBL] [Abstract] [Full Text] [Related]
6. [Peripheral Blood Laboratory Test Results Combined with tcf1+CD8+ T Lymphocytes
Ratio to Predict the Response and Prognosis of Immunotherapy to
Advanced lung cancer].
Luo H; Dai S; Li Y; Tian P; Li Q; Cai X
Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):605-614. PubMed ID: 37752540
[TBL] [Abstract] [Full Text] [Related]
7. Characterization of TCF-1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients.
Jiang K; Liu S; Chen Y; Xu Z; Xu Z; Qian B; Ding Q; Cui H; Sui Y; Cao D; Xu W; Shen M
Thorac Cancer; 2023 Sep; 14(27):2745-2753. PubMed ID: 37536668
[TBL] [Abstract] [Full Text] [Related]
8. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
9. Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma.
Gaglia G; Burger ML; Ritch CC; Rammos D; Dai Y; Crossland GE; Tavana SZ; Warchol S; Jaeger AM; Naranjo S; Coy S; Nirmal AJ; Krueger R; Lin JR; Pfister H; Sorger PK; Jacks T; Santagata S
Cancer Cell; 2023 May; 41(5):871-886.e10. PubMed ID: 37059105
[TBL] [Abstract] [Full Text] [Related]
10. Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy.
Maniar R; Wang PH; Washburn RS; Kratchmarov R; Coley SM; Saqi A; Pan SS; Hu J; Shu CA; Rizvi NA; Henick BS; Reiner SL
Cancer Immunol Res; 2023 Feb; 11(2):164-170. PubMed ID: 36512052
[TBL] [Abstract] [Full Text] [Related]
11. PD-1 combination therapy with IL-2 modifies CD8
Hashimoto M; Araki K; Cardenas MA; Li P; Jadhav RR; Kissick HT; Hudson WH; McGuire DJ; Obeng RC; Wieland A; Lee J; McManus DT; Ross JL; Im SJ; Lee J; Lin JX; Hu B; West EE; Scharer CD; Freeman GJ; Sharpe AH; Ramalingam SS; Pellerin A; Teichgräber V; Greenleaf WJ; Klein C; Goronzy JJ; Umaña P; Leonard WJ; Smith KA; Ahmed R
Nature; 2022 Oct; 610(7930):173-181. PubMed ID: 36171288
[TBL] [Abstract] [Full Text] [Related]
12. tcf1
Koh J; Kim S; Woo YD; Song SG; Yim J; Han B; Lim S; Ahn HK; Mun S; Kim JS; Keam B; Kim YA; Lee SH; Jeon YK; Chung DH
Eur J Cancer; 2022 Oct; 174():10-20. PubMed ID: 35970031
[TBL] [Abstract] [Full Text] [Related]
13. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
14. hnf1a-AS1: A Tumor-associated Long Non-coding RNA.
Liu Y; Zhao F; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(21):1720-1729. PubMed ID: 35619319
[TBL] [Abstract] [Full Text] [Related]
15. AXL targeting restores PD-1 blockade sensitivity of
Li H; Liu Z; Liu L; Zhang H; Han C; Girard L; Park H; Zhang A; Dong C; Ye J; Rayford A; Peyton M; Li X; Avila K; Cao X; Hu S; Alam MM; Akbay EA; Solis LM; Behrens C; Hernandez-Ruiz S; Lu W; Wistuba I; Heymach JV; Chisamore M; Micklem D; Gabra H; Gausdal G; Lorens JB; Li B; Fu YX; Minna JD; Brekken RA
Cell Rep Med; 2022 Mar; 3(3):100554. PubMed ID: 35492873
[TBL] [Abstract] [Full Text] [Related]
16. Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell lung cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy.
Kim KH; Pyo H; Lee H; Oh D; Noh JM; Ahn YC; Yoon HI; Moon H; Lee J; Park S; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Ku BM; Ahn MJ; Shin EC
Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):415-425. PubMed ID: 35150786
[TBL] [Abstract] [Full Text] [Related]
17. Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study.
Kruger SF; Lohneis A; Abendroth A; Berger AW; Ettrich TJ; Waidmann O; Kapp M; Steiner B; Kumbrink J; Reischer A; Haas M; Westphalen CB; Zhang D; Miller-Phillips L; Burger PJ; Kobold S; Werner J; Subklewe M; von Bergwelt-Baildon M; Kunzmann V; Seufferlein T; Siveke JT; Sinn M; Heinemann V; Ormanns S; Boeck S
ESMO Open; 2022 Feb; 7(1):100388. PubMed ID: 35121522
[TBL] [Abstract] [Full Text] [Related]
18. Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.
Lehtiö J; Arslan T; Siavelis I; Pan Y; Socciarelli F; Berkovska O; Umer HM; Mermelekas G; Pirmoradian M; Jönsson M; Brunnström H; Brustugun OT; Purohit KP; Cunningham R; Foroughi Asl H; Isaksson S; Arbajian E; Aine M; Karlsson A; Kotevska M; Gram Hansen C; Drageset Haakensen V; Helland Å; Tamborero D; Johansson HJ; Branca RM; Planck M; Staaf J; Orre LM
Nat Cancer; 2021 Nov; 2(11):1224-1242. PubMed ID: 34870237
[TBL] [Abstract] [Full Text] [Related]
19. TCF-1
Fang X; Wu G; Hua J; Zhao P; Shan M; Wang N; Zeng Y; Ding T; Zhu H; Zhu X; Zhang L; Liu Y; Zheng L; Yi X; Gao S
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2653-2660. PubMed ID: 34725738
[TBL] [Abstract] [Full Text] [Related]
20. Antigen dominance hierarchies shape tcf1
Burger ML; Cruz AM; Crossland GE; Gaglia G; Ritch CC; Blatt SE; Bhutkar A; Canner D; Kienka T; Tavana SZ; Barandiaran AL; Garmilla A; Schenkel JM; Hillman M; de Los Rios Kobara I; Li A; Jaeger AM; Hwang WL; Westcott PMK; Manos MP; Holovatska MM; Hodi FS; Regev A; Santagata S; Jacks T
Cell; 2021 Sep; 184(19):4996-5014.e26. PubMed ID: 34534464
[TBL] [Abstract] [Full Text] [Related]
[Next]
